专利检索 ap:("Seiki Matsuno" OR "Iwao Sasaki" OR "Akira Ohneda" OR "Kazuyuki Sasaki" OR "Yohei Natori" OR "Tomohisa Nagasaki") AND inv:"Tomohisa Nagasaki" 第 1 页

1.

发明授权
Therapeutic agent for digestive tract diseases using glicentin 失效
标题翻译：使用glicentin消化道疾病的治疗剂

公开(公告)号：US5547938A

公开(公告)日：1996-08-20

申请号：US377833

申请日：1995-01-25

申请人： Seiki Matsuno , Iwao Sasaki , Akira Ohneda , Kazuyuki Sasaki , Yohei Natori , Tomohisa Nagasaki

发明人： Seiki Matsuno , Iwao Sasaki , Akira Ohneda , Kazuyuki Sasaki , Yohei Natori , Tomohisa Nagasaki

IPC分类号： A61K31/00 , A61K38/22 , A61K38/26 , A61P1/00 , A61P1/04 , A61P1/14 , A61P43/00 , C07K14/00 , C07K14/575 , C07K14/605

CPC分类号： A61K38/26

摘要： Therapeutic agents for the digestive tract diseases which comprise glicentin as active ingredients.

摘要翻译： 消化道疾病的治疗剂，其包含胃肠素作为活性成分。

2.

发明授权
Therapeutic agent for digestive tract diseases 失效
标题翻译：消化道疾病治疗剂

公开(公告)号：US5432156A

公开(公告)日：1995-07-11

申请号：US193863

申请日：1994-02-09

申请人： Seiki Matsuno , Iwao Sasaki , Akira Ohneda , Kazuyuki Sasaki , Yohei Natori , Tomohisa Nagasaki

发明人： Seiki Matsuno , Iwao Sasaki , Akira Ohneda , Kazuyuki Sasaki , Yohei Natori , Tomohisa Nagasaki

IPC分类号： A61K31/00 , A61K38/22 , A61K38/26 , A61P1/00 , A61P1/04 , A61P1/14 , A61P43/00 , C07K14/00 , C07K14/575 , C07K14/605

CPC分类号： A61K38/26

摘要： Therapeutic agents for the digestive tract diseases which comprise glicentin as active ingredients.

摘要翻译： 消化道疾病的治疗剂，其包含胃肠素作为活性成分。

3.

发明授权
Medicaments comprising glicentin as active ingredient 失效
标题翻译：药物包含胃肠素作为活性成分

公开(公告)号：US5616558A

公开(公告)日：1997-04-01

申请号：US83501

申请日：1993-06-30

申请人： Akira Ohneda , Kazuyuki Sasaki , Yohei Natori , Tomohisa Nagasaki

发明人： Akira Ohneda , Kazuyuki Sasaki , Yohei Natori , Tomohisa Nagasaki

IPC分类号： A61K38/00 , A61K38/26 , C07K14/605 , C07K14/00

CPC分类号： C07K14/605 , A61K38/26

摘要： Agents for stimulating insulin secretion and for treating diabetes which comprise glicentin as an active ingredient.

摘要翻译： 用于刺激胰岛素分泌和用于治疗糖尿病的药物，其包含作为活性成分的格列汀。

4.

发明授权
Medicaments comprising glicentin as active ingredient 失效

公开(公告)号：US5700776A

公开(公告)日：1997-12-23

申请号：US415939

申请日：1995-04-03

申请人： Akira Ohneda , Kazuyuki Sasaki , Yohei Natori , Tomohisa Nagasaki

发明人： Akira Ohneda , Kazuyuki Sasaki , Yohei Natori , Tomohisa Nagasaki

IPC分类号： A61K38/00 , A61K38/26 , C07K14/605 , C07K7/34

CPC分类号： C07K14/605 , A61K38/26

摘要： Agents for stimulating insulin secretion and for treating diabetes which comprise glicentin as an active ingredient.

5.

发明授权
Autonomously replicating plasmid and saccharomycopsis lipolytica transformed therewith 失效
标题翻译：自动更换血浆和脂肪肝脂蛋白

公开(公告)号：US5118625A

公开(公告)日：1992-06-02

申请号：US285032

申请日：1988-12-16

申请人： Shuichi Aiba , Tomohisa Nagasaki , Kohji Uchida

发明人： Shuichi Aiba , Tomohisa Nagasaki , Kohji Uchida

IPC分类号： C12N15/09 , C12N1/19 , C12N15/00 , C12N15/68 , C12N15/81 , C12R1/645

CPC分类号： C12N15/815 , C12N15/68 , Y10S435/911

摘要： The plasmid of the present invention contains Leu 2 gene (.beta.-isopropylmaleate dehydrogenase gene) from Saccharomycopsis lipolytica and an autonomously replicating sequence (hereafter referred to as ARS) and can be a shuttle vector between Escherichia coli and Saccharomycopsis lipolytica since it is produced from shuttle vector pVC 1 of Escherichia coli and Saccharomyces cerevisiae. An exogenous useful gene is inserted into the plasmid of the present invention, namely, shuttle vector to transform Escherichia coli, whereby a large quantity of plasmids are obtained. It becomes possible to produce a useful substance in Saccharomycopsis lipolytica as a host using the plasmid.